|Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution|
SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...
Nature 461 (7265), 809-813, 2009
|Tumor-associated macrophages and survival in classic Hodgkin's lymphoma|
C Steidl, T Lee, SP Shah, P Farinha, G Han, T Nayar, A Delaney, ...
New England Journal of Medicine 362 (10), 875-885, 2010
|New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients|
D Haase, U Germing, J Schanz, M Pfeilstöcker, T Nösslinger, ...
Blood, The Journal of the American Society of Hematology 110 (13), 4385-4395, 2007
|Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone|
NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ...
Journal of clinical oncology 30 (28), 3452, 2012
|New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international …|
J Schanz, H Tüchler, F Solé, M Mallo, E Luño, J Cervera, I Granada, ...
Journal of clinical oncology 30 (8), 820, 2012
|Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival|
NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ...
Blood, The Journal of the American Society of Hematology 114 (11), 2273-2279, 2009
|MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers|
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377-381, 2011
|Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment|
C Steidl, JM Connors, RD Gascoyne
Journal of Clinical Oncology 29 (14), 1812-1826, 2011
|Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing|
RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1256-1265, 2013
|Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma|
R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ...
Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012
|The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia|
A Kuendgen, M Schmid, R Schlenk, S Knipp, B Hildebrandt, C Steidl, ...
Cancer 106 (1), 112-119, 2006
|Cooperative epigenetic modulation by cancer amplicon genes|
L Rui, NCT Emre, MJ Kruhlak, HJ Chung, C Steidl, G Slack, GW Wright, ...
Cancer cell 18 (6), 590-605, 2010
|Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma|
R Rahal, M Frick, R Romero, JM Korn, R Kridel, FC Chan, B Meissner, ...
Nature medicine 20 (1), 87, 2014
|Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies|
DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ...
Journal of clinical oncology 33 (26), 2848, 2015
|Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma|
DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ...
Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014
|Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas|
KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ...
The Journal of pathology 224 (3), 328-333, 2011
|The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery|
HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ...
Cell 167 (5), 1145-1149, 2016
|Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary …|
U Germing, B Hildebrandt, M Pfeilstöcker, T Nösslinger, P Valent, ...
Leukemia 19 (12), 2223-2231, 2005
|Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute …|
A Kuendgen, S Knipp, F Fox, C Strupp, B Hildebrandt, C Steidl, ...
Annals of hematology 84 (1), 61-66, 2005
|Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial|
KL Tan, DW Scott, F Hong, BS Kahl, RI Fisher, NL Bartlett, RH Advani, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3280-3287, 2012